Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Incannex Healthcare Inc. (IXHL : NSDQ)

• Company Description    Incannex Healthcare Limited is a clinical-stage pharmaceutical company developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for unmet medical needs. Incannex Healthcare Limited is based in MELBOURNE, Australia. Number of Employees: 12

• Price / Volume Information    Yesterday's Closing Price: $0.27 Daily Weekly Monthly 20 Day Moving Average: 6,401,697 shares Shares Outstanding: 346.23 (millions) Market Capitalization: $93.17 (millions) Beta: 7.46 52 Week High: $1.88 52 Week Low: $0.08 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -28.62% -27.54% 12 Week -14.44% -17.35% Year To Date -24.83% -24.73%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 525 Collins Street - Melbourne,VI 3008 AUS ph: 61-4-0984-0786 fax: - investors@incannex.com http://www.incannex.com

• General Corporate Information    Officers Joel Latham - Chief Executive Officer and President Troy Valentine - Chairman Joseph Swan - Chief Financial Officer Peter Widdows - Director George Anastassov - Director Peer Information Incannex Healthcare Inc. (GSAC) Incannex Healthcare Inc. (CASI) Incannex Healthcare Inc. (ALCD.) Incannex Healthcare Inc. (OMNN) Incannex Healthcare Inc. (CGPI.) Incannex Healthcare Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 45333F109 SIC: 2834 Fiscal Year Fiscal Year End: June Last Reported Quarter: 12/01/25 Next Expected EPS Date: 05/21/26 Share - Related Items Shares Outstanding: 346.23 Most Recent Split Date: (:1) Beta: 7.46 Market Capitalization: $93.17 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.02 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.04 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/21/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.22 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 93.94% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -83.78% ROE 12/31/25 - -150.92 09/30/25 - -196.72 06/30/25 - -671.36 ROA 12/31/25 - -127.94 09/30/25 - -153.63 06/30/25 - -298.35 Current Ratio 12/31/25 - - 09/30/25 - 47.51 06/30/25 - 2.86 Quick Ratio 12/31/25 - - 09/30/25 - 47.51 06/30/25 - 2.86 Operating Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Net Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Pre-Tax Margin 12/31/25 - - 09/30/25 - -398,933.31 06/30/25 - -54,517.44 Book Value 12/31/25 - - 09/30/25 - 0.22 06/30/25 - 0.07 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00

Powered by Zacks Investment Research ©